Blood pressure changes after renal denervation at 10 European expert centers

Alexandre Persu(Cliniques Universitaires Saint-Luc), Jan A. Staessen(Jagiellonian University), Arif Elvan(Isala), Marc Sapoval(Délégation Paris 5), Jean Renkin(Radiance Technologies (United States)), F.E. Fadl Elmula(Oslo University Hospital), A. Adiyaman(Isala), Fadi Jokhaji(Karolinska Institutet), Anne Taylor(The University of Adelaide), Francesca Severino(UCLouvain), Patrick B. Mark(Queen Elizabeth University Hospital), Antoinette Péchère-Bertschi(University Hospital of Geneva), Matthieu Monge(Délégation Paris 5), Thomas Kahan(Karolinska Institutet), J. Rosa(General University Hospital in Prague), Michel Azizi(Inserm), Michel Burnier(Gdańsk Medical University), Bert Andersson(Sahlgrenska University Hospital), Yu Jin(KU Leuven), Sverre E. Kjeldsen(Oslo University Hospital), Leo Jacobs(KU Leuven), Grégoire Wuerzner(University of Lausanne), Sebastian Völz(Sahlgrenska University Hospital), Marie Baelen(Cliniques Universitaires Saint-Luc), Petr Widimský(Universidad Americana)
Journal of Human Hypertension
September 26, 2013
10.1038/jhh.2013.88
Cited by 149

Related Papers

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
|The Lancet|2003|3.8k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
|The Lancet|2005|2.9k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k